Global Immune Health Probiotic Supplements Market - 2024-2031

Global Immune Health Probiotic Supplements Market - 2024-2031


Global Immune Health Probiotic Supplements Market reached US$ 220.1 million in 2023 and is expected to reach US$ 394.6 million by 2031, growing with a CAGR of 8.7% during the forecast period 2024-2031.

Consumers are increasingly adopting preventive healthcare measures, including the use of dietary supplements like probiotics, to support immune function and overall well-being. There is growing consumer awareness and interest in immune health with the rising incidence of immune-related health issues and the proactive approach to wellness, boosting the market growth.

The introduction of new products, formulations and technologies related to the development of immune health probiotic supplements, provides a huge range of growth opportunities for the market in the global market. For instance, in May 2022, BIO & ME, a Singapore-based company under AMILI introduced five probiotic formulations aimed at enhancing immunity, well-being, energy levels, mental health, and physical strength.

North America dominates the market growth with high probiotic supplement demand in the region. According to the Food and Health Survey conducted by the International Food Information Council in April 2022, around 33% of respondents in United States try to include probiotics in their diets, with 60% aiming to do so daily. Also, it is stated that 51% of Americans incorporate probiotics into their diets to promote gut health, 33% use them to bolster immune function.

Dynamics

Rising Prevalence of Inflammatory Diseases

As inflammatory diseases such as autoimmune disorders, allergies and gastrointestinal conditions become more prevalent, there is a heightened awareness among consumers about the importance of immune health. In May 2023, the University of Oxford reported a study of 22 million people showing that autoimmune disorders affect about 1 in 10 individuals.

Similarly, NIH reported that worldwide, 3 of 5 people die due to chronic inflammatory diseases like chronic respiratory diseases, heart disorders, cancer, obesity and diabetes. The prevalence of diseases associated with chronic inflammation is anticipated to increase for the next 30 years in the United States according to an NIH report updated August 2023. Many of these diseases are linked to imbalances in the immune system increasing demand for probiotic supplements that support the immune system.

New Product Introductions

With the growing consumer willingness to explore various new and innovative health-promoting products including immune health probiotic supplements, manufacturers are diversifying their probiotic supplement offerings, to meet the demand. Manufacturers are offering products that claim to reduce inflammation, support gut health, or enhance overall immune function, appealing directly to consumers seeking alternative or adjunctive treatments to conventional products.

The new offerings include developing specific formulations and strains tailored to target inflammation and support immune health. For instance, in March 2023, Nutrazee, a startup based in Hyderabad, unveiled Nutrazee Probiotic Gummies, which are designed to enhance digestive and immune health for both children and adults. These gummies feature a patented and clinically validated probiotic strain known as Bacillus Coagulans.

High Cost of Immune Health Probiotic Supplements

Developing probiotic supplements involves extensive research to identify and validate effective strains and other criteria to demonstrate the safety and efficacy of the final product, adding more R&D costs. Similarly, maintaining high-quality standards in probiotic manufacturing requires adherence to stringent regulations and quality control measures which also result in higher production costs.

The high cost of probiotic supplements may limit price-sensitive consumers from purchasing these products, especially consumers with backgrounds of limited disposable incomes. Consumers may prefer alternative immune health products, such as vitamins, minerals, and herbal supplements hindering the market growth.

Segment Analysis

The global immune health probiotic supplements market is segmented based on strain, form, distribution channel, age group, application and region.

Increasing Gut Health Issues

The global immune health probiotic supplements market is segmented based on application into hair growth, gut health, respiratory tract infection and others. The gut health segment dominates the global market with the increasing gut health issues worldwide. According to NIH, a comprehensive multinational study using internet surveys found that over 40% of the global population experiences gastrointestinal issues.

The prevalence rates of diarrhea, constipation, or irritable bowel syndrome (IBS), were reported to be 4.7%, 11.7% and 4.1%, respectively. It is also reported that around 60 to 70 million people in U.S. live with a digestive disease. With the increasing digestive health disorders and strong consumer awareness regarding the link between digestive and immune health is positively impacting segment growth.

Geographical Penetration

Increasing Health Consciousness In North America

North America dominated the global immune health probiotic supplements market with rising health concerns and demand for better health and wellness products. According to the American Autoimmune Related Diseases Association, 50 million Americans have one or more autoimmune diseases. It is reported that 1 in every 5 Americans has an autoimmune disease. With the increasing autoimmune disorders, the demand for products to support immunity is incraesing vigorously in this region.

The health consciousness motivated consumers to take up health-promoting products such as dietary supplements with a strong awareness of the benefits of probiotics for immune health. The Council for Responsible Nutrition surveyed in August 2022 and stated that among 3,133 U.S. adults aged 18 and older, including 2,342 adults they indicated they use dietary supplements occasionally, regularly, or seasonally, driving the demand for various supplements including probiotics to support health.

Competitive Landscape

The major global players in the market include Bayer AG, Amway Corp., Now Foods, The Himalayan Drug Company, Zenith Nutrition, BioGaia UK, Zeroharm Sciences Private Limited, The Good Bug, Nordic Naturals and Hyperbiotics.

COVID-19 Impact Analysis

The probiotic supplements market faced disruptions in supply chains during the pandemic. This impacted the availability of raw materials, manufacturing capabilities, and distribution logistics, leading to temporary shortages and price fluctuations. In contrast, the heightened public awareness about the importance of immune health and the consumers becoming more proactive in seeking ways to support their immune systems, led to increased demand for immune health supplements, including probiotics.

By Strain
• Lactobacillus
• Bifidobacterium
• Other

By Form
• Tablet
• Capsules
• Liquid
• Powder
• Gel
• Others

By Distribution Channel
• Pharmacies/Drugstores
• Supermarkets and Hypermarkets
• Dental Clinics
• E-commerce
• Other

By Age-Group
• Children
• Adults
• Seniors

By Application
• Hair Growth
• Gut Health
• Respiratory Tract Infection
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Russia
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In March 2023, Nutrazee, a Hyderabad-based startup renowned for its innovative vegan supplements and gummy vitamins, introduced its latest offering: Nutrazee Probiotic Gummies for Digestive & Immune Health. This new addition to their product lineup is specially formulated to promote digestive and immune health, catering to both children and adults alike.
• In January 2022, PanTheryx, a company specializing in digestive and immune health products, introduced two sugar-free probiotic gummy products to its TruBiotics line for children and adults. TruBiotics is launching its first line of gummies, featuring B. subtilis DE111 for gut and immune support, complemented by vitamin C or D.
• In May 2022, BIO & ME, a Singapore-based company under AMILI introduced five probiotic formulations aimed at enhancing immunity, well-being, energy levels, mental health, and physical strength.

Why Purchase the Report?
• To visualize the global immune health probiotic supplements market segmentation based on strain, form, distribution channel, age group, application and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of immune health probiotic supplements market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global immune health probiotic supplements market report would provide approximately 78 tables, 78 figures and 235 pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Strain
3.2. Snippet by Form
3.3. Snippet by Distribution Channel
3.4. Snippet by Age Group
3.5. Snippet by Application
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Inflammatory Diseases
4.1.1.2. New Product Introductions
4.1.2. Restraints
4.1.2.1. High Cost of Immune Health Probiotic Supplements
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Strain
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
7.1.2. Market Attractiveness Index, By Strain
7.2. Lactobacillus
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bifidobacterium
7.4. Other
8. By Form
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
8.1.2. Market Attractiveness Index, By Form
8.2. Tablet
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Liquid
8.5. Powder
8.6. Gel
8.7. Others
9. By Distribution Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Pharmacies/Drugstores
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Supermarkets and Hypermarkets
9.4. Dental Clinics
9.5. E-commerce
9.6. Other
10. By Age Group
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.1.2. Market Attractiveness Index, By Age Group
10.2. Children
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Adults
10.4. Seniors
11. By Application
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2. Market Attractiveness Index, By Application
11.2. Hair Growth
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Gut Health
11.4. Respiratory Tract Infection
11.5. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Bayer AG
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Amway Corp.
14.3. Now Foods
14.4. The Himalayan Drug Company
14.5. Zenith Nutrition
14.6. BioGaia UK
14.7. Zeroharm Sciences Private Limited
14.8. The Good Bug
14.9. Nordic Naturals
14.10. Hyperbiotics
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings